Identification and characterisation of transforming growth factor beta-regulated vascular smooth muscle cell genes

Cytokine

Volumn 12, Issue 4, 2000, Pages 348-354

  Adam, Paul J ^a   Clesham, Gerald J ^a   Flynn, Paul D ^a   Weissberg, Peter L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Differential mRNA display; Gene expression; Transforming growth factor beta; Vascular smooth muscle cells

Indexed keywords

CATHEPSIN B; DNA; MESSENGER RNA; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; AORTA; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; VASCULAR SMOOTH MUSCLE;

EID: 0033923297     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0559     Document Type: Article

References (28)

1. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 314:1986;488-500.
2. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor β1 during repair of arterial injury. J Clin Invest. 88:1991;904-910.
3. Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Wier L. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest. 90:1992;1582-1592.
4. Assoian RK, Sporn MB. Type-beta transforming growth-factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol. 102:1986;1217-1223.
5. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Sporn MB. Expression and secretion of type-beta transforming growth-factor by activated human macrophages. Proc Natl Acad Sci U S A. 84:1987;6020-6024.
6. Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nature Med. 1:1995;74-79.
7. Owens GK, Geisterfer AAT, Yang YWH, Komoriya A. Transforming growth factor-β-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol. 107:1988;771-780.
8. Grainger DJ, Kemp PR, Witchell CM, Weissberg PL, Metcalfe JC. Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase. Biochem J. 299:1994;227-235.
9. Bjorkerud S. Effects of transforming growth factor-beta-1 on human arterial smooth-muscle cells in vitro. Arterioscler Thromb. 11:1991;892-902.
10. Hautmann MB, Madsen CS, Owens GK. A transforming growth factor β (TGFβ) control element drives TGFβ-induced stimulation of smooth muscle α-actin gene expression in concert with two CArG elements. J Biol Chem. 272:1997;10948-10956.
11. Owens GK. Regulation of differentiation of vascular-smooth muscle cells. Physiol Rev. 75:1995;487-517.
12. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb. 11:1991;1223-1230.
13. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257:1992;967-971.
14. Liang P, Averboukh L, Pardee AB. Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucl Acids Res. 21:1993;3269-3275.
15. Bauer D, Muller H, Reich J, Riedel H, Ahrenkiel V, Warthoe P, Strauss M. Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucl Acids Res. 21:1993;4272-4280.
16. Lyons RM, Gentry LE, Purchio AF, Moses HL. Mechanism of activation of latent recombinant transforming growth factor-beta-1 by plasmin. J Cell Biol. 110:1990;1361-1367.
17. Oursler MJ, Riggs L, Spelsberg TC. Glucocorticoid-induced activation of latent transforming growth factor-β by normal human osteoblast-like cells. Endocrinology. 133:1993;2187-2196.
18. Grainger DJ, Hesketh TR, Metcalfe JC, Weissberg PL. A large accumulation of non-muscle myosin occurs at first entry into M-phase in rat vascular smooth muscle cells. Biochem J. 277:1991;145-151.
19. Karess RE, Chang XJ, Edwards KA, Kulkarni S, Aguilera I, Kiehart DP. The regulatory light chain of non-muscle myosin is encoded by spaghetti-squash, a gene required for cytokinesis in Drosophila. Cell. 65:1991;1177-1189.
20. Uchiyama Y, Waguri S, Sato N, Watanabe T, Ishido K, Kominami E. Cell and tissue distribution of lysosomal cysteine proteinases, cathepsin-B, cathepsin-H, and cathepsin-L, and their biological roles. Acta Histo Et Cyto. 27:1994;287-308.
21. Miyazono K, Heldin C-H. Role for carbohydrate structures in TGF-beta latency. Nature. 338:1989;158-160.
22. Wakefield LM, Smith DM, Flanders KC, Sporn MB. Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem. 263:1988;7646-7654.
23. Munger JS, Huang X, Kawakatsu H, Griffiths MJD, Dalton SL, Wu J, Pittet J-F, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D. The integrin αvβ6 binds and activates latent TGFβ1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell. 96:1998;319-328.
24. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N. Thrombospondin-1 is a major activator of TGF-beta 1 in vivo. Cell. 93:1998;1159-1170.
25. Munger JS, Harpel JG, Gleizes P-E, Mazzieri R, Nunes I, Rifkin DB. Latent transforming growth factor-β: structural features and mechanisms of activation. Kidney Int. 51:1997;1376-1382.
26. Leto G, Tumminello F-M, Pizzolanti G, Montalto G, Soresi M, Gebbia N. Lysosomal cathepsins B and L and stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications. Oncology. 54:1997;79-83.
27. Adam PJ, Weissberg PL, Cary NRB, Shanahan CM. Polyubiquitin is a new phenotypic marker of contractile vascular smooth muscle cells. Cardiovasc Res. 33:1997;416-421.
28. Libby P, O'Brien KV. Culture of arterial smooth-muscle cells in a defined serum-free medium. J Cell Physiol. 115:1983;217-223.